These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26157331)

  • 21. Phagotopes derived by antibody screening of phage-displayed random peptide libraries vary in immunoreactivity: studies using an exemplary monoclonal antibody, CII-C1, to type II collagen.
    Davies JM; Rowley MJ; MacKay IR
    Immunol Cell Biol; 1999 Dec; 77(6):483-90. PubMed ID: 10571668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The localization of two mimic epitopes of lipopolysaccharide binding protein and the preparation of their tandem multiple antigen peptide.
    Feng YK; Yang QH; Liu YS; Xu JC; Qian GS; Wang YH
    J Immunol Methods; 2010 Oct; 362(1-2):60-9. PubMed ID: 20833181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A general method for characterization of humoral immunity induced by a vaccine or infection.
    Legutki JB; Magee DM; Stafford P; Johnston SA
    Vaccine; 2010 Jun; 28(28):4529-37. PubMed ID: 20450869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational analysis of high-density peptide microarray data with application from systemic sclerosis to multiple sclerosis.
    Hecker M; Lorenz P; Steinbeck F; Hong L; Riemekasten G; Li Y; Zettl UK; Thiesen HJ
    Autoimmun Rev; 2012 Jan; 11(3):180-90. PubMed ID: 21621003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgE and IgG4 epitope mapping by microarray immunoassay reveals the diversity of immune response to the peanut allergen, Ara h 2.
    Shreffler WG; Lencer DA; Bardina L; Sampson HA
    J Allergy Clin Immunol; 2005 Oct; 116(4):893-9. PubMed ID: 16210066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions.
    Stephen CW; Helminen P; Lane DP
    J Mol Biol; 1995 Apr; 248(1):58-78. PubMed ID: 7537340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of linear epitopes recognized by monoclonal antibodies with gene-fragment phage display libraries.
    Petersen G; Song D; Hügle-Dörr B; Oldenburg I; Bautz EK
    Mol Gen Genet; 1995 Dec; 249(4):425-31. PubMed ID: 8552047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Peptide library screening to detect a previously unknown linear diagnostic epitope: proof of principle by use of lyme disease sera.
    Hamby CV; Llibre M; Utpat S; Wormser GP
    Clin Diagn Lab Immunol; 2005 Jul; 12(7):801-7. PubMed ID: 16002626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-specific IgG antibodies in stage IV long-time survival breast cancer patients.
    Hansen MH; Ostenstad B; Sioud M
    Mol Med; 2001 Apr; 7(4):230-9. PubMed ID: 11471567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping a conserved conformational epitope from the M protein of group A streptococci.
    Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
    Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition.
    Niman HL; Houghten RA; Walker LE; Reisfeld RA; Wilson IA; Hogle JM; Lerner RA
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):4949-53. PubMed ID: 6192445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genuine and apparent cross-reaction of polyclonal antibodies to proteins and peptides.
    Leder L; Wendt H; Schwab C; Jelesarov I; Bornhauser S; Ackermann F; Bosshard HR
    Eur J Biochem; 1994 Jan; 219(1-2):73-81. PubMed ID: 8307037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptides designed to spatially depict the Epstein-Barr virus major virion glycoprotein gp350 neutralization epitope elicit antibodies that block virus-neutralizing antibody 72A1 interaction with the native gp350 molecule.
    Tanner JE; Coinçon M; Leblond V; Hu J; Fang JM; Sygusch J; Alfieri C
    J Virol; 2015 May; 89(9):4932-41. PubMed ID: 25694592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
    Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
    Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection and application of peptide mimotopes of MPT64 protein in Mycobacterium tuberculosis.
    Yang H; Liu ZH; Zhang LT; Wang J; Yang HS; Qin LH; Jin RL; Feng YH; Cui ZL; Zheng RJ; Hu ZY
    J Med Microbiol; 2011 Jan; 60(Pt 1):69-74. PubMed ID: 20930053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic and immunological mimicry of peptide mimotopes of Lewis carbohydrate antigens.
    Luo P; Agadjanyan M; Qiu J; Westerink MA; Steplewski Z; Kieber-Emmons T
    Mol Immunol; 1998 Sep; 35(13):865-79. PubMed ID: 9839555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping of the IgE and IgG4 sequential epitopes of milk allergens with a peptide microarray-based immunoassay.
    Cerecedo I; Zamora J; Shreffler WG; Lin J; Bardina L; Dieguez MC; Wang J; Muriel A; de la Hoz B; Sampson HA
    J Allergy Clin Immunol; 2008 Sep; 122(3):589-94. PubMed ID: 18774394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivity of antibodies to heteroclitic peptides based on the Chlamydia trachomatis major outer-membrane protein.
    Yxfeldt G; Fröman G; Mårdh PA; Ward ME
    Microbiology (Reading); 1994 Apr; 140 ( Pt 4)():815-21. PubMed ID: 7516794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of MHC class II-restricted T-cell epitopes in prostate-specific membrane antigen.
    Schroers R; Shen L; Rollins L; Xiao Z; Sonderstrup G; Slawin K; Huang XF; Chen SY
    Clin Cancer Res; 2003 Aug; 9(9):3260-71. PubMed ID: 12960111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Could immunosignatures technology enable the development of a preventative cancer vaccine?
    Shen L; Hansen DT; Johnston SA; Legutki JB
    Expert Rev Vaccines; 2014 May; 13(5):577-9. PubMed ID: 24641768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.